diff --git a/pages/STOP2030___Web.md b/pages/STOP2030___Web.md
index 1f9631d1..41dacae3 100644
--- a/pages/STOP2030___Web.md
+++ b/pages/STOP2030___Web.md
@@ -17,7 +17,8 @@
 			- Qualification at EMA for art. 58
 			- Safety of IVM up to 600μg/kg alone and in coformulation with albendazole
 			- Demonstrated efficacy agrainst T. trichiura in a pivotal trial in Sub-Saharan Africa
-		- FDC of ivm/alb has the lowe
+		- FDC of ivm/alb has the lowest level of investment risk of all candidates for Combination for STH treatment (STH Drug Combinations Expert Meeting, BMGF, April 2016)
+		-
 		- Investigadores principales de cada uno de los partners
 		- Timeline y milestones (cuáles se han cumplido?)
 			- __Proposed safety and effectiveness study__